Literature DB >> 26049307

Surgical Site Infection Reduction Program: Challenges and Opportunities.

Kevin G Shea1, Alexandra C Styhl, Howard A King, Jerrie Hammons, Melissa Clapp.   

Abstract

Surgical site infections (SSIs) make up about 23% of hospital-acquired infections and may cost up to 10 billion dollars annually in direct medical expenses. St. Luke's Health System of Boise, Idaho implemented a committee to reduce its incidence of SSIs, focusing on the orthopaedic and neurosurgical departments. After identifying risk factors associated with patient medical comorbidities, operating room practices, and type of procedure, Project Zero recommended changes. The implementation of a preoperative clinic and protocol management of environmental and procedural factors reduced the hospitals rate by 50%. Project Zero continues to research best practices for clean room management and preventative care, striving to reach the overall goal of zero infections.

Entities:  

Mesh:

Year:  2015        PMID: 26049307     DOI: 10.1097/BPO.0000000000000549

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  3 in total

1.  Eliminating Healthcare-Associated Infections in Iran: A Qualitative Study to Explore Stakeholders' Views.

Authors:  Atefeh Esfandiari; Hedayat Salari; Arash Rashidian; Hossein Masoumi Asl; Abbas Rahimi Foroushani; Ali Akbari Sari
Journal:  Int J Health Policy Manag       Date:  2018-01-01

2.  Hospital Burdens of Patients With Cerebral Palsy Undergoing Posterior Spinal Fusion for Scoliosis.

Authors:  Albert T Anastasio; Ndeye F Guisse; Kevin X Farley; John M Rhee
Journal:  Global Spine J       Date:  2020-11-18

Review 3.  Implementation methods of infection prevention measures in orthopedics and traumatology - a systematic review.

Authors:  Benedikt Marche; Meike Neuwirth; Christiane Kugler; Bertil Bouillon; Frauke Mattner; Robin Otchwemah
Journal:  Eur J Trauma Emerg Surg       Date:  2020-09-10       Impact factor: 3.693

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.